We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Greater Drug Pricing Transparency Needed, Senate Finance Panel Told
Greater Drug Pricing Transparency Needed, Senate Finance Panel Told
Greater transparency of pharmaceutical pricing is the key to reducing the nation’s prescription drug tab, according to multiple comments sent to the Senate Finance Committee.